Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.

[1]  A. Young.  Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone , 2004, Psychopharmacology.

[2]  I. Sukhotina,et al.  Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice , 2000, Psychopharmacology.

[3]  A. Bespalov,et al.  Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. , 1998, The Journal of pharmacology and experimental therapeutics.

[4]  H. Jones,et al.  Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. , 1998, Behavioural pharmacology.

[5]  C. Parsons,et al.  Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies , 1997, Neuroscience & Biobehavioral Reviews.

[6]  P. Popik,et al.  Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. , 1997, The Journal of pharmacology and experimental therapeutics.

[7]  P. Herrling.  Excitatory amino acids : clinical results with antagonists , 1997 .

[8]  P. Skolnick,et al.  The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence , 1996, Pharmacology Biochemistry and Behavior.

[9]  F. Vocci,et al.  The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal , 1995, Neuropsychopharmacology.

[10]  W. Schmidt,et al.  N-Methyl-d-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats , 1995, Neuroscience Letters.

[11]  L. Cervo,et al.  Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference , 1995, Brain Research.

[12]  E. Sellers,et al.  The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. , 1992, Life sciences.

[13]  H. Akil,et al.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. , 1991, Science.

[14]  S. Holtzman,et al.  Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[15]  S. Goldberg,et al.  Enhanced sensitivity to behavioral effects of naltrexone in rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[16]  R. Balster,et al.  Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline. , 1989, The Journal of pharmacology and experimental therapeutics.

[17]  S. Sparber,et al.  Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine. , 1977, Life sciences.